Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Historical Holders from Q3 2024 to Q1 2025

Symbol
TRAW on Nasdaq
CUSIP
68232V884
Type / Class
Equity / Common Stock, par value $.01 per share
Shares outstanding
3.05M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.14M
Holdings value
$10.1M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
17
Number of buys
10
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORBIMED ADVISORS LLC 19.9% $1.83M 761K ORBIMED ADVISORS LLC Dec 31, 2024
Ayrton Capital LLC 9.9% $969K 404K Ayrton Capital LLC Dec 31, 2024
Ikarian Capital, LLC 9.99% $946K 394K Ikarian Capital, LLC Dec 31, 2024
PERCEPTIVE ADVISORS LLC 9.9% $928K 387K Perceptive Advisors LLC Dec 31, 2024
Alyeska Investment Group, L.P. 9.9% $725K 302K Alyeska Investment Group, L.P. Dec 31, 2024

Institutional Holders of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$18 0
2024 Q4 1.14M $10.1M +$4.4M $8.88 17
2024 Q3 646K $3.8M +$3.74M $5.88 10